Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Oct 29
Love0

GLP-1 Receptor Agonists for the Dermatologist: Uses and Considerations

By Chuck Lin No Comments
INTRODUCTIONThe glucagon-like peptide-1 receptor agonists (GLP1RAs) are a widely popularized drug class due to their notable success in promoting weight loss. The GLP1RAs, dulaglutide, exenatide, semaglutide, liraglutide, tirzepatide, and lixisenatide…
Read More
Oct 29
Love0

FULL SUPPLEMENT: Real-World Clinical Experience Combining A Neuro-Peptide Serum And Botulinum Toxin Type-A Injections

By Chuck Lin No Comments
In this supplement:Real-World Clinical Experience With a Neuro-Peptide Serum in Combination With Botulinum Toxin Type-A InjectionsWe evaluated real-life experiences of a topical neuro-peptide serum containing 2% acetyl hexapeptide-8, 2% dipeptide…
Read More
Oct 29
Love0

INDIVIDUAL ARTICLE: Real-World Clinical Experience With a Neuro-Peptide Serum in Combination With Botulinum Toxin Type-A Injections

By Chuck Lin No Comments
INTRODUCTIONBy 2050, the World Health Organization (WHO) estimates that the world's population of people aged 65 years and older will have more than doubled from 761 million in 2021.1 As…
Read More
Oct 29
Love0

Attitudes on, Practices, and Recommendations for Visible Light Protection Amongst Dermatology Practitioners

By Chuck Lin No Comments
INTRODUCTIONExposure to solar radiation (SR) is associated with a range of adverse effects on the skin, including photocarcinogenesis, sunburn, photoaging, and pigmentation. While the primary focus of SR-induced pathologies has…
Read More
Oct 29
Love0

INDIVIDUAL ARTICLE: All for One and One for All: The Three Musketeers of Topical Acne Treatment and the Current Landscape

By Chuck Lin No Comments
INTRODUCTIONAcne is one of the most prevalent dermatological conditions, affecting millions worldwide. It not only has a significant physical impact, but also contributes to psychological distress, including low self-esteem and…
Read More
Oct 29
Love0

FULL SUPPLEMENT: Topical Acne Treatment: What’s Behind the Scenes in 2024

By Chuck Lin No Comments
In this supplement:VEHICLES ALWAYS MATTEROver the past several years, the field of acne treatments, which had been relatively unchanged, has welcomed a variety of innovations. From new molecules and mechanisms…
Read More
Oct 29
Love0

New Formulations of Acyclothymidine Dinucleosides Reduce Damaging Effects of Ultraviolet Radiation in an Ex Vivo Skin Model

By Chuck Lin No Comments
INTRODUCTIONDespite numerous public warnings about protecting the skin against sun's UV exposure and extensive research into topical protective formulations, the incidence of melanoma and non-melanoma skin cancers continues to rise.1…
Read More
Oct 29
Love0

Treatment of Mild to Severe Acne Vulgaris With a 650-Microsecond 1064-nm Nd:YAG Laser

By Chuck Lin No Comments
INTRODUCTIONAcne affects approximately 50 million people in the United States.1 Therapies include retinoids, antibiotics, hormones, lights, lasers, and various combinations of these modalities.2 Topical and/or oral medications are associated with…
Read More
Oct 29
Love0

INDIVIDUAL ARTICLE: VEHICLES ALWAYS MATTER

By Chuck Lin No Comments
Over the past several years, the field of acne treatments, which had been relatively unchanged, has welcomed a variety of innovations. From new molecules and mechanisms of action to previously…
Read More
Oct 29
Love0

Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants With Moderate-to-Severe Acne: The Patient Journey

By Chuck Lin No Comments
INTRODUCTIONTreatment of acne vulgaris is difficult due to its chronicity, long treatment time course, and low patient adherence.1,2 The main treatment goal is to clear lesions quickly to manage and/or…
Read More
Oct 23
Love0

Critical Insights on Preparation of Platelet-Rich Plasma in Tubes With a Thixotropic Gel Separator

By Chuck Lin No Comments
INTRODUCTIONPlatelet-rich plasma (PRP) is a blood-derived product containing a higher concentration of platelets in plasma relative to whole blood, which supports its rejuvenating effects. The use of PRP from a…
Read More
Oct 23
Love0

Safety and Effectiveness of Synchronized Monopolar Radiofrequency and HIFES in Patients Injected With Botulinum Toxin

By Chuck Lin No Comments
INTRODUCTIONTo mitigate the signs of aging, including wrinkles and fine lines resulting from loss of collagen, elastin, and hyaluronic acid, individuals often resort to cosmetic interventions.1-5 Botulinum toxin (BT) has…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • What’s Old is New: The Translational Understanding of and Approaches to Dermatoporosis May 13, 2025
  • Safety of Topical Dermatologic Medications in Pregnancy: What You Need to Know May 12, 2025
  • Successful Treatment of Sacral Pressure Injury With ACU-D1 May 10, 2025
  • Decoding Derm: What’s the Diagnosis? National Melonoma and Skin Cancer Awareness Month May 9, 2025
  • JDD Article on HA Fillers Gets a Beauty Spotlight—Here’s Why Dermatologists Should Take Note May 8, 2025

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |      ADVERTISING POLICY

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search